ClinicalTrials.gov
public full text
Public Domain
Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer
The purpose of this study is to investigate if sentinel lymph node biopsy is a reliable staging tool for breast cancer patients planned for neoadjuvant chemotherapy (=before breast surgery) and if, in that case, it is safe to omit axillary lymph node dissection if the sentinel lymph node is free of metastasis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy#833015
- Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy#828651
- Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer#854768
- Lymphatic Mapping After Previous Breast Surgery#845006
- Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence#1095124
Record · ID 1228568
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive